Bingjing Intelligent Medical Completes Tens of Millions of Yuan Series Pre-A Financing
China Suzhou-based Bingjing Intelligent Medical (苏州冰晶智能医疗科技有限公司) closes tens of millions of yuan Series PreA Financing led by Dalton Venture (道彤投资) and followed by SND Financial Holdings (苏高新金控) and Marathon Venture Partners (远毅资本), for the development, clinical trials, and marketing of the next generation of high-definition and high-speed Intracardiac Echocardiography (ICE) ultrasound products.
Founded in October 2021, Bingjing Intelligent Medical focuses on cardiovascular interventional imaging, designing, developing, and producing dedicated digital interventional imaging products for cardiac and vascular diseases.
The company’s founder, Zhang Jihong (张吉宏), who worked at the global headquarters of GE Healthcare, has over 10 years of experience in the medical device industry, from upstream product development to downstream marketing and sales.
The core team members are senior experts from leading medical device companies such as GE Healthcare, Philips, Siemens Healthineers, Johnson & Johnson MedTech and Abbott.
The company has invested significant funds and manpower in the research and development of intracardiac ultrasound products, continues to improve the overall performance of the products, and will build the first ICE automated batch production line in China.
The Company has established an R&D and process manufacturing centre of several thousand square metres, equipped with the world’s most advanced precision R&D equipment, the only acoustic simulation testing equipment in China, and the only automated production and testing system in China.
